EE382 Cost-Utility Analysis of Avacopan for the Treatment of Anca-Associated Vasculitis (AAV) Patients in the UK
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.628
https://www.valueinhealthjournal.com/article/S1098-3015(22)02832-7/fulltext
Section Title :
Section Order :
10165
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02832-7&doi=10.1016/j.jval.2022.09.628